The current valuation score of Beyondspring Inc is 8.40, ranking 125 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -6.29, which is -84.87% below the recent high of -0.95 and -2513.56% above the recent low of -164.34.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.